Position in SCLX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$119
-$100 QoQ
Shares Held
18
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $3,714,565,940 across 18 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
825,867 | $759,607,690 | |
| 2 | ABBV |
AbbVie Inc.
|
3,043,902 | $662,018,245 | |
| 3 | JNJ |
Johnson & Johnson
|
2,389,655 | $584,127,268 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
5,947,732 | $360,729,945 | |
| 5 | PFE |
Pfizer Inc
|
9,904,502 | $278,118,416 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,966,938 | $274,132,149 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,206,233 | $265,387,767 | |
| 8 | AMGN |
Amgen Inc
|
651,459 | $229,215,849 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $119 | 18 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $219 | 18 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $146,221 | 7,430 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $15,113 | 2,566 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||